The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Open accessAbstract
Exhausted CD8+ T (T ex) cells in chronic infections and cancer have limited effector function, high co-expression of inhibitory receptors and extensive transcriptional changes compared with effector (T eff) or memory (T mem) CD8+ T cells. T ex cells are important clinical targets of checkpoint blockade and other immunotherapies. Epigenetically, T ex cells are a distinct immune subset, with a unique chromatin landscape compared with T eff and T mem cells. However, the mechanisms that govern the transcriptional and epigenetic development of T ex cells remain unknown. Here we identify the HMG-box transcription factor TOX as a central regulator of T ex cells in mice. TOX is largely dispensable for the formation of T eff and T mem cells, but it is critical for exhaustion: in the absence of TOX, T ex cells do not form. TOX is induced by calcineurin and NFAT2, and operates in a feed-forward loop in which it becomes calcineurin-independent and sustained in T ex cells. Robust expression of TOX therefore results in commitment to T ex cells by translating persistent stimulation into a distinct T ex cell transcriptional and epigenetic developmental program.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“which transcriptionally and epigenetically programs CD8+ T cell exhaustion [52].”
From Single-cell transcriptome reveals the reprogramming of immune microenvironment during the transition from MASH to HCC (2025) · cites this paper as [52]
The cited source says what the claim attributes to it.
In the citing paper
“Treatment‐induced declines in PD‐1+ CD8 T cells are consistent with the possibility that thymus regeneration treatment epigenetically reprograms “exhausted” CD8 T cells (T EX), a recently characterized distinct PD‐1+ CD8 population (Khan et al., 2019).”
From Reversal of epigenetic aging and immunosenescent trends in humans. (2019) · cites this paper as Khan et al., 2019
In the citing paper
“The excessive antigen density and kinetics of antigen exposure in solid tumors can drive exhaustion or dysfunction of T cells (Khan et al., 2019; Wherry, 2011).”
From Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies (2020) · cites this paper as Khan et al., 2019
In the citing paper
“Furthermore, bulk RNA-seq analysis of isolated cells (ND naïve, HFHC Tem, HFHC Trm, and RES Trm) revealed that both Trm subsets from HFHC mice and RES mice expressed core signature genes of Trm21–24 with exceptions including Itgae (CD103) and Eomes (Fig. 4d).”
From CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells (2021) · cites this paper as [24]
In the citing paper
“CD8 T cells are typically regarded as a uniform population with cytotoxic function; however, recent studies have highlighted the diversity of the CD8 T-cell population (5)(6)(7)(8)(9).”
From The Next Decade of Immune Checkpoint Therapy (2021) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. (2013) · Nature Methods · doi:10.1038/nmeth.2688 · Cited by 6,422
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Self-citationMaster Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 4,057
Self-citationSuper-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Zheng, C., Zheng, L., Yoo, J.-K., Guo, H., Zhang, Y., Guo, X., Kang, B., Hu, R., Huang, J. Y., Zhang, Q., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.035 · Cited by 2,152
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Cited by
Sorted by citations
Items 901–1,000 of 1,001
Stepwise Tfh cell differentiation revisited: new advances and long-standing questions
Schroeder, A. R., Zhu, F., & Hu, H. (2021) · Faculty Reviews · doi:10.12703/r/10-3 · Cited by 10
Herda, S., Heimann, A., Obermayer, B., Ciraolo, E., Althoff, S., Ruß, J., Grunert, C., Busse, A., Bullinger, L., Pezzutto, A., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33523 · Cited by 11
Cao, H. L., Kim, D. H., Howard, A., Moz, H., Wasnik, S., Baylink, D. J., Chen, C.-S., Reeves, M. E., Mirshahidi, S., Xiao, J., et al. (2021) · Neoplasia · doi:10.1016/j.neo.2021.11.003 · Cited by 11
Ren, J., Zhuo, Y., He, F., Lv, L., Xing, M., Guo, Y., Zhang, Y., Liu, J., Li, Y., Bai, T., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200301 · Cited by 10
IRF4 downregulation improves sensitivity and endurance of CAR T cell functional capacities
Harrer, D. C., Bezler, V., Hartley, J., Herr, W., & Abken, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1185618 · Cited by 12
Kusnadi, A., Ramírez-Suástegui, C., Fajardo, V., Chee, S., Meckiff, B. J., Simon, H. A., Pelosi, E., Seumois, G., Ay, F., Vijayanand, P., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.09.194027 · Cited by 10
Clonal relationships between Tph and Tfh cells in patients with SLE and in murine lupusPreprint
Sasaki, T., Sowerby, J. M., Xiao, Y., Wang, R., Samarpita, S., Abe, T., Marks, K. E., Horisberger, A., Gao, Y., Lee, P. Y., et al. (2025) · Research Square · doi:10.1101/2025.01.27.635189 · Cited by 11
Selck, C., Jhala, G., George, D. J. D., Kwong, C.-T. J., Christensen, M. K., Pappas, E. G., Liu, X., Ge, T., Trivedi, P., Kallies, A., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2315419121 · Cited by 10
BATF and BATF3 deficiency alters CD8+ effector/exhausted T cells balance in skin transplantation
Li, C., Liu, Z., Wang, Z., Yim, W. Y., Huang, Y., & Chen, Y. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00792-0 · Cited by 9
Ebihara, T., Yamada, T., Fuchimukai, A., Takasuga, S., Endo, T., Yamada, T., & Tatematsu, M. (2024) · International Immunology · doi:10.1093/intimm/dxae032 · Cited by 9
Ebi3 Binding to IFN-γ and IL-10 Limits Their Function
Scott, E. N., Ye, C., Yano, H., Lipatova, Z., Brunazzi, E. A., Vignali, K. M., Workman, C. J., & Vignali, D. A. A. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2400236 · Cited by 9
Liu, M., Akahori, Y., Imai, N., Wang, L., Negishi, K., Kato, T., Fujiwara, H., Miwa, H., Shiku, H., & Miyahara, Y. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010248 · Cited by 9
SLAMF7 defines subsets of human effector CD8 T cells
Kared, H., Tan, C. T. Y., Narang, V., Tan, S. W., Chin, H. X., Wei, A. T. S., Lum, J., Ruíz-Mateos, E., Rajasuriar, R., Kamarulzaman, A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-80971-5 · Cited by 10
Single-cell RNA sequencing in ovarian cancer: Current progress and future prospects
Chong, Z. X. (2025) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2025.01.002 · Cited by 9
Wang, K., Ou, K., Zeng, Y., Yue, C., Zhuo, Y., Wang, L., Chen, H., & Tu, S. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104729 · Cited by 9
Tang, M., Qaiyum, Z., Lim, M., & Inman, R. D. (2025) · iScience · doi:10.1016/j.isci.2025.112715 · Cited by 10
Jia, T., Guo, Y., Cheng, X. M., Zhou, Z., Xu, X., Liu, H., & Yang, X. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70425 · Cited by 9
Self-citationBodogai, M., Park, B. S., Braikia, F.-Z., Naqing, F., Kumaraswami, K., Chen, C., Ragonnaud, E., Stack, S. M., Ormanns, S., Guenther, M., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00966-3 · Cited by 9
Fang, R., Huang, B., Li, Y., Cai, Z., Deng, Y., Cen, X., Sun, W. Y., Zhang, J., Xu, Z., Guo, W., et al. (2025) · Advanced Science · doi:10.1002/advs.202516348 · Cited by 9
“Dissecting the role of T cell exhaustion in cancer progression: a multifaceted approach“
Li, X., & Song, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1646292 · Cited by 12
Zhu, Q., Zhang, J.-S., Nie, C.-P., Liu, X.-F., Zhan, L., Li, M., Zeng, X.-L., He, J., Huang, H., Xia, X., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69350-y · Cited by 10
TOX drives CD4+ TH1 effector function, antitumor immunity and autoimmune pathology
Naizir, B., Scott, A., Zumbo, P., Grassmann, S. A., Frost, J. N., Sun, J. C.-Y., Betel, D., & Schietinger, A. (2026) · Nature Immunology · doi:10.1038/s41590-026-02453-2 · Cited by 11
Kimura, Y., & Sumiyoshi, M. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154076 · Cited by 9
Regulation and Immunotherapeutic Targeting of the Epigenome in Exhausted CD8 T Cell Responses
Ford, B. R., & Poholek, A. C. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200681 · Cited by 9
Luo, L., Feng, P., Yang, Q., Lv, W., Meng, W., Yin, Z., Li, Z., Sun, G., Dong, Z., & Yang, M. (2023) · Theranostics · doi:10.7150/thno.81198 · Cited by 10
Barboy, O., Katzenelenbogen, Y., Shalita, R., & Amit, I. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0010 · Cited by 10
Lee, M. H., Theodoropoulos, J., Huuhtanen, J., Bhattacharya, D., Järvinen, P., Tornberg, S., Nísen, H., Mirtti, T. K., Uski, I., Kumari, A. N., et al. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0514 · Cited by 10
Pollard, J. M., Hynes, G. E., Yin, D., Mandal, M., Gounari, F., Alegre, M., & Chong, A. S. (2024) · JCI Insight · doi:10.1172/jci.insight.176381 · Cited by 9
Immunopathology caused by impaired CD8 + T‐cell responses
Aichele, P., Neumann‐Haefelin, C., Ehl, S. R., Thimme, R., Cathomen, T., Boerries, M., & Hofmann, M. (2022) · European Journal of Immunology · doi:10.1002/eji.202149528 · Cited by 12
Bello, A. D., Gouin, A., Chaubet, C., Kamar, N., & Treiner, E. (2022) · Scientific Reports · doi:10.1038/s41598-022-15705-6 · Cited by 9
Jerby‐Arnon, L., Tooley, K., Escobar, G., Dandekar, G., Madi, A., Goldschmidt, E., Lambden, C., Rozenblatt–Rosen, O., Anderson, A. C., & Regev, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.31.466532 · Cited by 9
Overcoming T-cell exhaustion: New therapeutic targets in HCC immunotherapy
Seimiya, T., Otsuka, M., & Fujishiro, M. (2023) · Hepatology · doi:10.1097/hep.0000000000000039 · Cited by 9
Espinosa-Carrasco, G., Scrivo, A., Zumbo, P., Dave, A., Betel, D., Hellmann, M. D., Burt, B. M., Lee, H., & Schietinger, A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.03.547423 · Cited by 9
Obesity, bone marrow adiposity, and leukemia: Time to act
Kumar, V., & Stewart, J. H. (2023) · Obesity Reviews · doi:10.1111/obr.13674 · Cited by 8
Kim, H., Park, H. H., Kim, H. N., Seo, D., Hong, K. S., Jang, J. G., Seo, E. U., Kim, I., Jeon, S., Son, B., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2319322121 · Cited by 9
Chronic viral infection alters PD-1 locus subnuclear localization in cytotoxic CD8+ T cells
Sacristán, C., Youngblood, B., Lu, P., Bally, A. P. R., Xu, J., McGary, K., Hewitt, S. L., Boss, J. M., Skok, J. A., Ahmed, R., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114547 · Cited by 8
Wu, B., Koehler, A. N., & Westcott, P. M. K. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.08.002 · Cited by 9
Metabolic Regulation of T Cell Exhaustion
Wu, H., Prados, M. C., & Vaeth, M. (2025) · Immune discovery. · doi:10.70322/immune.2025.10005 · Cited by 10
Mechanisms underlying resistance to CAR-T cell therapy and strategies for enhancement
Wu, A., Zhang, T., Yu, H., Cao, Y., Zhang, R., Shao, R., Liu, B., Chen, L., Xu, K., Chen, W., et al. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.04.002 · Cited by 9
Mai, L. T., Swaminathan, S., Nguyen, T. H., Collette, É., Charpentier, T., Carmona‐Pérez, L., Loucif, H., Lamarre, A., Heinonen, K. M., Langlais, D., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00485-2 · Cited by 8
Enhancing the potency of CAR-T cells against solid tumors through transcription factor engineering
Chen, R., Chen, L., Tang, Y. R., Xiaolin, S., Wang, Y., Tang, P., Shentu, X., & Sun, J. (2025) · JCI Insight · doi:10.1172/jci.insight.193048 · Cited by 9
Leveraging Systems Immunology to Optimize Diagnosis and Treatment of Inborn Errors of Immunity
Mauracher, A. A., & Henrickson, S. E. (2022) · Frontiers in Systems Biology · doi:10.3389/fsysb.2022.910243 · Cited by 8
Hu, P., Ma, J., & Chen, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1126916 · Cited by 10
Systems biology approaches to unravel lymphocyte subsets and function
Kim, Y., Greenleaf, W. J., & Bendall, S. C. (2023) · Current Opinion in Immunology · doi:10.1016/j.coi.2023.102323 · Cited by 7
Duan, Z., Li, Y.-X., Qiu, Y., Shen, Y., Wang, Y., Zhang, Y., Zhu, B., Yu, X., Tan, X., Chen, W., et al. (2024) · Clinical & Translational Immunology · doi:10.1002/cti2.1499 · Cited by 8
MERTK inhibition selectively activates a DC – T-cell axis to provide anti-leukemia immunity
Huelse, J. M., Bhasin, S. S., Jacobsen, K. M., Yim, J., Thomas, B. E., Branella, G. M., Bakhtiari, M., Chimenti, M. L., Baxter, T. A., Raikar, S. S., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02408-2 · Cited by 10
Tian, Y., Guo, J., Mao, L., Chen, Z., Zhang, X., Li, Y., Zhang, Y., Zha, X., & Luo, O. J. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03969-w · Cited by 10
Cravedi, P., Fribourg, M., Zhang, W., Yi, Z., Zaslavsky, E., Nudelman, G., Anderson, L., Hartzell, S., Brouard, S., & Heeger, P. S. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15979 · Cited by 9
Kubo, T., Shinkawa, T., Kikuchi, Y., Murata, K., Kanaseki, T., Tsukahara, T., Hirohashi, Y., & Torigoe, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.679095 · Cited by 9
Wu, P., Xiang, T., Wang, J., Lv, R., Ma, S., Yuan, L., Wu, G., & Che, X. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01092-w · Cited by 8
An overview of multiplexed analyses of CAR T-cell therapies: insights and potential
DePriest, B. P., Vieira, N., Bidgoli, A., & Paczesny, S. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.1992276 · Cited by 9
Li, S., Yang, S., & Hong, Y. (2022) · BMC Cancer · doi:10.1186/s12885-022-10336-6 · Cited by 8
The Emerging Role of Lymphocyte Activation Gene 3 in the Cancer Immunotherapy
Cui, X., Peng, M., & Chen, H. (2022) · ONCOLOGIE · doi:10.32604/oncologie.2022.023641 · Cited by 8
Multiomics analyses reveal pathological mechanisms of HBV infection and integration in liver cancer
Guo, M., Zhao, L., Jiang, C., Jia, C., Liu, H., Zhou, W., Songyang, Z., & Xiong, Y. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28980 · Cited by 10
Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer
Aderonke, A. B., Ibrahim, R. B., & Huang, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184624 · Cited by 8
Parallels Between the Antiviral State and the Irradiated State
McGee, H. M., Marciscano, A. E. E., Campbell, A. M., Monjazeb, A. M., Kaech, S. M., & Teijaro, J. R. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa190 · Cited by 8
Toor, S. M., Nair, V. S., Saleh, R., Taha, R. Z., Murshed, K., Al‐Dhaheri, M., Khawar, M., Ahmed, A., Kurer, M. A., Nada, M. A., et al. (2021) · Vaccines · doi:10.3390/vaccines9040334 · Cited by 8
Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer
Zhang, S., Wang, C., Xia, W., Duan, H., Qian, S., & Shen, H. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s339996 · Cited by 8
Cell Penetrating Peptide-Based Self-Assembly for PD-L1 Targeted Tumor Regression
Guo, F., Ke, J., Fu, Z., Han, W., & Wang, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413314 · Cited by 8
Multiplexed Single-cell Metabolic Profiles Organize the Spectrum of Cytotoxic Human T CellsPreprint
Hartmann, F. J., Mrdjen, D., McCaffrey, E., Glass, D. R., Greenwald, N. F., Bharadwaj, A., Khair, Z., Baranski, A., Baskar, R., Angelo, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.17.909796 · Cited by 8
Targeting Angiogenesis for Advanced Hepatocellular Carcinoma
Eso, Y. (2020) · Internal Medicine · doi:10.2169/internalmedicine.5923-20 · Cited by 8
McCutcheon, S. R., Swartz, A. M., Brown, M. C., Barrera, A., Amador, C. M., Siklenka, K., Humayun, L. L., Isaacs, J. M., Reddy, T. E., Nair, S. K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.01.538906 · Cited by 8
Salomon, N., Helm, A., Selmi, A., Fournier, C., Diken, M., Schrörs, B., Scholz, M., Kreiter, S., Durante, M., & Vascotto, F. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2023.12.042 · Cited by 7
Zhang, C., Chen, Y.-Y., Chen, S., Wang, Y., Yuan, Y., Yang, X., Hu, W. M., Chen, B., Qi, Z., Huse, J. T., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-2289 · Cited by 7
Jin, Z., Li, Y., Hao, Y., Wang, M., Wang, C., Du, S., Zeng, W., & Zong, Z. (2025) · International Journal of Oncology · doi:10.3892/ijo.2025.5728 · Cited by 8
Zhang, P., Whipp, E. C., Skuli, S. J., Gharghabi, M., Saygin, C., Sher, S., Carroll, M. P., Pan, X., Eisenmann, E. D., Lai, T.-H., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci184021 · Cited by 9
Programmed cell death protein 1 in cancer cells
Wei, C., Liu, M., & Zhang, W. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02155-6 · Cited by 7
Gfi1 controls the formation of effector-like CD8+ T cells during chronic infection and cancer
Ojo, O. A., Shen, H., Ingram, J. T., Bonner, J. A., Welner, R. S., Lacaud, G., Zajac, A. J., & Shi, L. Z. (2025) · Nature Communications · doi:10.1038/s41467-025-59784-1 · Cited by 9
Fan, Z., Liu, Y., Lin, X., Zhang, J., Chen, J., Yi, S., Hu, C., Liu, X., Guo, C., Xu, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61439-0 · Cited by 8
Epigenetic reprogramming holds promise in enhancing anti-tumor efficacy of CAR T cell therapy
Zheng, Y., Zhu, Q., Li, X., Ge, T., Wang, S., Jia, R., Yang, L., Wang, Y., & Zhuang, A. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108649 · Cited by 7
Guo, K., Yang, L., Huang, Z., Qian, K., Shi, Y., Fei, M., Feng, Y., Chen, Z., Qiu, M., Tang, L., et al. (2025) · Advanced Science · doi:10.1002/advs.202417672 · Cited by 10
Epigenetic priming as a driver of memory recall and dysfunction in T cells
Metzemaekers, M., Rinzema, N. J., & Stadhouders, R. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20241433 · Cited by 8
Wang, Z., Zhang, R., Xu, Y., Yue, B., Zhang, J., & Wang, F. (2025) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v17.i8.109489 · Cited by 7
BACH2 promotes seeding and establishment of long-lived HIV-1 reservoir in memory CD4+ T cells
Gao, H., Li, Y., Tiwari, R., Pinzone, M. R., Qin, X., Clark, K. M., Nicholson, S. K., Yao, T., Rome, K., Scaglione, M., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102311 · Cited by 7
Within and beyond the tumor: Mechanisms of glioblastoma-induced immunosuppression
Puviindran, B. J., Wallace, S., Ayasoufi, K., Lerner, E., & Fecci, P. E. (2025) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaf006 · Cited by 9
Exploring the Tumor Microenvironment in Osteosarcoma: Driver of Resistance and Progression
Schmidt, A. A., Prasad, A., Huisman, A. R., Wakefield, M. R., & Fang, Y. (2025) · Cancers · doi:10.3390/cancers17193106 · Cited by 9
Zhang, Y., Tsui, Y., Lee, J. M., Cheung, T. T., Ho, D. W., & Ng, I. O. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-013516 · Cited by 8
Uridine depletion impairs CD8⁺ T cell antitumor activity through N-glycosylation
Xiao, J., Li, Z., Ding, Y., Zhu, K., Zheng, Z., Zhang, Y., Weng, J., Wang, F., Zhang, Y., Zeng, S., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.11.016 · Cited by 8
Muth, A., Holzem, A. M. E., Neumann, A.-S., Bücklein, V., Subklewe, M. S., & Philipp, N. (2026) · Med · doi:10.1016/j.medj.2026.101031 · Cited by 9
Nose, Y., Yasumizu, Y., Saito, T., Nakamura, Y., Jinushi, K., Fujikawa, K., Momose, K., Yamashita, K., Tanaka, K., Yamamoto, K., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70751-2 · Cited by 7
The transcription factor TOX is involved in the regulation of T-cell exhaustion in neuroblastoma
Pei, M., Chai, W., Wang, X., Duan, Y., Wang, H., Xi, Y., Mou, W., Wang, W., Chen, X., Zhang, H., et al. (2022) · Immunology Letters · doi:10.1016/j.imlet.2022.06.004 · Cited by 8
Immunology of hepatitis D virus infection: General concepts and present evidence
Hoblos, R., & Kefalakes, H. (2022) · Liver International · doi:10.1111/liv.15424 · Cited by 7
Mcintosh, C. M., Allocco, J., Wang, P., McKeague, M. L., Cassano, A., Wang, Y., Xie, S. Z., Hynes, G. E., Mora-Cartín, R., Abbondanza, D., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci168465 · Cited by 7
Bibliometric analysis of evolutionary trajectory and prospective directions of LAG-3 in cancer
Wang, J., Wang, S., Zhang, Y., & Zhang, W. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1329775 · Cited by 7
Multimodal delineation of a layer of effector function among exhausted CD8 T cells in tumors
Ray, A., Bassette, M. A., Hu, K. H., Pass, L. F., Courau, T., Samad, B., Combes, A. J., Johri, V., Davidson, B. R., Wai, K. C., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adt3537 · Cited by 10
Cell‐intrinsic mechanisms to restrain inflammatory responses in T lymphocytes
Džafo, E., Bianchi, N., & Monticelli, S. (2021) · Immunological Reviews · doi:10.1111/imr.12932 · Cited by 8
Kang, P., Li, Y., Hu, Z., Lei, M., Cheng, J., Guo, X., Zhang, L., Lin, S., & Yuan, Q. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108732 · Cited by 7
Zhang, L., & Nishi, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274494 · Cited by 8
Harabuchi, S., Khan, O., Bassiri, H., Yoshida, T., Okada, Y., Takizawa, M., Ikeda, O., Katada, A., & Kambayashi, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1032113 · Cited by 7
Self-citationLiao, Y., Hsu, S., & Chiou, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042416 · Cited by 7
Manipulating the TCR signaling network for cellular immunotherapy: Challenges & opportunities
Matson, C. A., & Singh, N. J. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.04.007 · Cited by 7
Olalekan, S. A., Xie, B., Back, R., Eckart, H., & Basu, A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.11.944561 · Cited by 7
Elliot, T. A. E., Lecky, D. A. J., & Bending, D. (2023) · Essays in Biochemistry · doi:10.1042/ebc20220247 · Cited by 6
Reversal of T-cell exhaustion: Mechanisms and synergistic approaches
Hu, Y., Zhang, Y., Shi, F., Yang, R., Yan, J., Han, T., & Guan, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112571 · Cited by 9
Wang, G., Xu, X.-N., Zhu, Z., Wang, K., & Li, F. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124512 · Cited by 6
Self-citationShort, S. M., Perez, M. D., Morse, A. E., Jennings, R. D., Howard, D. S., Foureau, D., Chojecki, A. L., David, C., Blaha, L. E., Shaw, Y., et al. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300827 · Cited by 7
TOX Does Not Drive Sepsis‐Induced T‐Cell Exhaustion
Qin, Y., Qian, Y., Liu, S., & Chen, R. (2024) · European Journal of Immunology · doi:10.1002/eji.202451395 · Cited by 7
Zhu, Z., Lou, G., Luo, Y., Yihunie, K. D., Hoar, J., Daniel, J., Evers, B. M., Yao, C., & Wu, T. (2025) · Aging Cell · doi:10.1111/acel.70109 · Cited by 6
Conceição-Neto, N., Pierson, W., Han, Q.-Z., Yao, Z.-Y., Wu, Q., Dockx, K., Aerts, L., Maeyer, D. D., Beyens, M., den Berge, K. V., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1421712 · Cited by 5
PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and a cell-extrinsic fashion
Pauken, K. E., Markson, S. C., Conway, T. S., Juneja, V. R., Shahid, O., Burke, K. P., Rowe, J. H., Nguyen, T. H., Collier, J. L., Walsh, J. M. L., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20230542 · Cited by 6
Metadata
- Authors
- Khan, O., Giles, J. R., McDonald, S., Manne, S., Ngiow, S. F., Patel, K. P., Werner, M. T., Huang, A. C., Alexander, K. A., Wu, J. E., Attanasio, J., Yan, P., George, S. M., Bengsch, B., Staupe, R. P., Donahue, G., Xu, W., Amaravadi, R. K., Xu, X., Karakousis, G. C., Mitchell, T. C., Schuchter, L. M., Kaye, J., Berger, S. L., & Wherry, E. J.
- Affiliations
- Arsenal Biosciences (United States) (US)
- University of Pennsylvania (US)
- University of Freiburg (DE)
- Abramson Cancer Center (US)
- Cedars-Sinai Medical Center (US)
- Parker Institute for Cancer Immunotherapy (US)
- Corresponding author
- Wherry, E. John
- ORCID
- Khan, Omar
- Giles, Josephine R.
- McDonald, Sierra
- Manne, Sasikanth
- Ngiow, Shin Foong
- Patel, Kunal P.
- Werner, Michael T.
- Huang, Alexander C.
- Alexander, Katherine A.
- Wu, Jennifer E.
- Attanasio, John
- Yan, Patrick
- Bengsch, Bertram
- Staupe, Ryan P.
- Donahue, Greg
- Xu, Wei
- Amaravadi, Ravi K.
- Xu, Xiaowei
- Karakousis, Giorgos C.
- Mitchell, Tara C.
- Schuchter, Lynn M.
- Kaye, Jonathan
- Berger, Shelley L.
- Wherry, E. John
- Venue
- Nature
- Published
- 2019-06-17
- Volume
- 571
- Issue
- 7764
- Pages
- 211-218
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6713202
- OpenAlex
- W2952815301
- Cited by
- 1,646
- References
- 63
- Citations by year
- 2026: 258 · 2025: 249 · 2024: 234 · 2023: 252 · 2022: 211 · 2021: 235 · 2020: 161 · 2019: 43
- FWCI
- 64.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (R01CA078831, F32CA221010, P30CA010815, P01CA210944)
- National Institute of Allergy and Infectious Diseases (R01AI115712, R01AI054977, R01AI105343, F30AI129263, U19AI117950, U19AI082630, P01AI108545)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- TOX transcription factor, CD8+ T cell exhaustion, chromatin landscape, epigenetic regulation, calcineurin, NFATc1, feed-forward loop, inhibitory receptors, chronic infection, cancer immunotherapy, checkpoint blockade, transcriptional programs
- MeSH terms
- Animals, Epistasis, Genetic, Female, Gene Expression Regulation, Genotype, Immunologic Memory, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Transcription, Genetic, Homeodomain Proteins, CD8-Positive T-Lymphocytes, Tumor Escape, Calcineurin, Calcium Signaling, Feedback, Physiological, NFATC Transcription Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
